A CLINICAL RESEARCH STUDY FOR ADULTS 50 TO 64 YEARS OF AGE
Are you interested in contributing to research on COVID-19 vaccines?
We are conducting a clinical study evaluating an investigational vaccine that may help protect against the Omicron JN.1 subvariant of COVID-19.
CONSIDER JOINING THIS STUDY
If you qualify and choose to participate:
- All study-related care is provided at no cost
- You may receive either the investigational vaccine or a placebo
- Study staff will closely monitor your health throughout the trial
- Travel or other expenses may be reimbursed
ABOUT THE STUDY
This research evaluates a single dose of the investigational NVX-CoV2705 vaccine
- Day 0: Screening and vaccination
- Symptom monitoring through a daily electronic diary
- Phone check-ins at Days 42, 90, and 180
- Nasal swab testing may be performed if COVID-19 symptoms develop
CONTACT US TODAY TO SEE IF YOU QUALIFY
786-772-0510
